Privigen 10% vial 400ML
Ended Awarded Last action
- Contract number
- SPE2DR26FHKR9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,779
Award facts
- Contract value 100% obligated
- $83,779.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $83.8K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for PRIVIGEN 10% vial 400mL, an intravenous immunoglobulin product used for immunological disorders. This delivery order, issued November 26, 2025, with an ultimate completion date of December 18, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this delivery order.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499.999 billion, was awarded November 13, 2025, with a completion date of December 31, 2036, and includes a 30-month base period with three additional 30-month option periods. Through this vehicle, the DLA can issue delivery orders for branded and generic prescription drugs, biologics, vaccines, and medical consumables to support recurring medical supply needs across the military healthcare system, with DMS Pharmaceutical Group's demonstrated performance on numerous prior delivery orders establishing its capability to fulfill specialized pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FHKR9?
SPE2DR26FHKR9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FHKR9 worth?
The government has obligated $83,779 on SPE2DR26FHKR9.
Is contract SPE2DR26FHKR9 an order under another contract?
Yes. SPE2DR26FHKR9 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.
Was contract SPE2DR26FHKR9 competed?
The extent of competition for SPE2DR26FHKR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award